Health and Medicine

‘A rather remarkable feat’

UNC-Chapel Hill researchers and industry scientists are working side by side in the same lab on Carolina’s campus to find a cure for HIV — and they’re getting closer. ViiV Healthcare and Carolina have recently announced that they have signed a second five-year, $20 million contract to continue their groundbreaking research to find a cure.

The Latest

  • ‘A rather remarkable feat’

    UNC-Chapel Hill researchers and industry scientists are working side by side in the same lab on Carolina’s campus to find a cure for HIV — and they’re getting closer. ViiV Healthcare and Carolina have recently announced that they have signed a second five-year, $20 million contract to continue their groundbreaking research to find a cure.

  • Transformational gift to fund new sports medicine complex

    The new complex will enable further advances in its world-leading traumatic brain injury research.

  • Carolina researchers make important scientific step toward an HIV cure

    Overcoming HIV latency is a major step toward creating a cure for HIV. For the first time, scientists at Carolina, Emory University and Qura Therapeutics – a partnership between Carolina and ViiV Healthcare – have found a new approach that can expose latent HIV.

  • Correcting vaccine misinformation is a difficult process, Carolina study shows

    UNC-Chapel Hill researchers examined how negative media coverage of the HPV vaccine impacted vaccination rates in Denmark to better understand the damage misinformation causes.

  • The ultimate telemedicine

    Blood clot expert Dr. Stephan Moll, professor of medicine in the School of Medicine, consulted NASA on how to treat a U.S. astronaut’s deep vein thrombosis during a mission on the International Space Station.

  • Pinnacle Hill announces first project agreement

    An alliance between UNC-Chapel Hill and Deerfield Management Company intends to advance Carolina innovations toward a possible new treatment against a devastating cancer.